Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease
Corresponding Author
C. FERRI MD
Rheumatology and Clinical Immunology Unit, Institute of Medical Pathology I Pisa, Italy.
Istituto Patologia Medica I, Università di Pisa. Via Roma 67, 1–56100 Pisa, Italy.Search for more papers by this authorG. LONGOMBARDO
Rheumatology and Clinical Immunology Unit, Institute of Medical Pathology I Pisa, Italy.
Search for more papers by this authorL. LA CIVITA
Rheumatology and Clinical Immunology Unit, Institute of Medical Pathology I Pisa, Italy.
Search for more papers by this authorF. LOMBARDINI
Rheumatology and Clinical Immunology Unit, Institute of Medical Pathology I Pisa, Italy.
Search for more papers by this authorR. CECCHETTI
The Gastroenterology and Hepatology Unit, Hospital of Pontedera, Pisa
Search for more papers by this authorM. A. CAGIANELLI
The Gastroenterology and Hepatology Unit, Hospital of Pontedera, Pisa
Search for more papers by this authorS. MARCHI
Gastroenterology and Hepatology Unit, Clinical Medicine I, University of Pisa
Search for more papers by this authorM. MONTI
The Gastroenterology and Hepatology Unit, Hospital of Pontedera, Pisa
Search for more papers by this authorA. L. ZIGNEGO
The Institute of Clinical Medicine II, University of Florence, Florence; Italy.
Hybridotest, Pasteur Institute, Paris, France
Search for more papers by this authorM. P. MANNS
Department of Gastroenterology and Hepatology, Centre for Internal Medicine, Hannover Medical School, Hannover, Germany
Search for more papers by this authorCorresponding Author
C. FERRI MD
Rheumatology and Clinical Immunology Unit, Institute of Medical Pathology I Pisa, Italy.
Istituto Patologia Medica I, Università di Pisa. Via Roma 67, 1–56100 Pisa, Italy.Search for more papers by this authorG. LONGOMBARDO
Rheumatology and Clinical Immunology Unit, Institute of Medical Pathology I Pisa, Italy.
Search for more papers by this authorL. LA CIVITA
Rheumatology and Clinical Immunology Unit, Institute of Medical Pathology I Pisa, Italy.
Search for more papers by this authorF. LOMBARDINI
Rheumatology and Clinical Immunology Unit, Institute of Medical Pathology I Pisa, Italy.
Search for more papers by this authorR. CECCHETTI
The Gastroenterology and Hepatology Unit, Hospital of Pontedera, Pisa
Search for more papers by this authorM. A. CAGIANELLI
The Gastroenterology and Hepatology Unit, Hospital of Pontedera, Pisa
Search for more papers by this authorS. MARCHI
Gastroenterology and Hepatology Unit, Clinical Medicine I, University of Pisa
Search for more papers by this authorM. MONTI
The Gastroenterology and Hepatology Unit, Hospital of Pontedera, Pisa
Search for more papers by this authorA. L. ZIGNEGO
The Institute of Clinical Medicine II, University of Florence, Florence; Italy.
Hybridotest, Pasteur Institute, Paris, France
Search for more papers by this authorM. P. MANNS
Department of Gastroenterology and Hepatology, Centre for Internal Medicine, Hannover Medical School, Hannover, Germany
Search for more papers by this authorAbstract
Abstract. Objectives. Mixed cryoglobulinaemia (MC) and autoimmune chronic hepatitis (AI-CH) are frequently associated with hepatitis C virus (HCV) chronic infection. Because HCV represents a possible common aetiological factor, the aim of the present study is to investigate the clinico-serological alterations of both MC and AI-CH and to verify a possible overlap between these disorders.
Setting. Patients from three tertiary referral centres.
Subjects. Two Italian series of 88 MC patients and 30 AI-CH type 1 were studied.
Results. MC and AI-CH share several clinico-sero-logical features. The patients' mean age (MC vs. AI-CH: 60 ± 9 vs. 57 ± 13 years), disease duration (10.5 ± 5 vs. 9.6 ± 6 years), and female/male ratio (3.4 vs. 3.3) were very similar in the two series. Typical hallmarks of MC, i.e. purpura, arthralgias, and weakness, circulating mixed cryoglobulins with rheumatoid factor activity, and hypocomplement-emia were also recorded in a significant number of AI-CH patients. Similarly, chronic active hepatitis was found in 68% of MC patients and its histological and serological alterations were comparable with those of AI-CH; moreover, amongst various auto-antibodies, antinuclear antibodies and/or anti-smooth-muscle antibodies were detected in half of the cases of MC. Anti-HCV antibodies, detected by second-generation Chiron elisa and riba, were present in a high percentage of both MC and AI-CH (94 vs. 80%), and frequently associated with HCV viraemia (86 vs. 77%). Finally, anti-GOR, the HCV-related autoantibodies, were found in half cases of MC and AI-CH.
Conclusions. On the whole, these data suggest that HCV in combination with other infectious and environmental and genetic factors can trigger a complex immunological disorder with different clinical patterns.
References
- 1 Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia. A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40: 837–56.
- 2 Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P et al. Mixed cryoglobulinaemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69: 287–308.
- 3 Maggiore Q, L'Abbate A, Bartolomeo F, Misefari F, Caccamo A, Martorano C et al. The role of circulating cryoglobulins and HBsAg in the pathogenesis of glomerulonephritis of essential mixed cryoglobulinemia. In: L Chiandussi, E Bartoli, S. Sherlock eds. Systemic Effect of HBsAg Immunocomplexes. Padova: Piccin, 1980; 242–51.
- 4 Bombardieri S, Ferri C, Migliorini P, Pontrandolfo A, Puccetti A, Vitali C et al. Cryoglobulins and immune complexes in essential mixed cryoglobulinemia. La Ricerca Clin Lab 1986; 16: 281–8.
- 5 Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC. Association between hepatitis B virus an essential mixed cryoglobulinemia. N Engl J Med 1977; 296: 1501–4.
- 6 Bombardieri S, Ferri C, Di Munno, O, Pasero G. Liver involvement in essential mixed cryoglobulinemia. La Ricerca Clin Lab 1979; 9: 361–8.
- 7 Ferri C, Marzo E, Longombardo G, Lombardini F, Greco F, Bombardieri S. Alpha-interferon in the treatment of mixed cryoglobulinemia patients. In: M Freund, SE Solman, eds. Proceedings International Cancer Update: Focus on Interferon Alfa 2b. Cannes: France, 1–4 November, 1990. Eur J Cancer 1991; 27(S4): 81–2.
- 8 Pascual M, Perrin L, Giostra E, Schifer JA. Hepatitis C virus in patients with Cryoglobulinemia type II. J Infect Dis 1990; 162: 569–70.
- 9 Ferri C, Greco F, Longombardo G, Palla P, Marzo E. Moretti A et al. Hepatitis C virus antibodies in mixed cryoglobulinaemia patients. Arthr Rheum 1991; 34: 1606–10.
- 10 Ferri C, Greco F, Longombardo G, Palla P, Marzo E, Moretti A et al. Antibodies against hepatitis C virus in mixed cryoglobulinaemia patients. Infection 1991; 19: 417–20.
- 11 Casato M, Pucillo LP, Laganà B, Taliani G, Goffredo F, Bonomo L. Cryoglobulinaemia and hepatitis C virus. Lancet 1991; i: 1047–8.
- 12 Ferri C, Greco F, Longombardo G, Palla P, Marzo E, Moretti A et al. Association between hepatitis C virus and mixed cryoglobulinaemia. Clin Exp Rheumatol 1991; 9: 621–4.
- 13 Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith H, McFarlane B et al. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; ii: 277–80.
- 14 Ferri C, Longombardo G, La Civita, L, Bombardiert S, Greco F, Highfield P et al. Hepatitis C virus, autoimmune liver disease and cryoglobulinemic hepatitis. J Hepatol 1992; 16: 242–3.
- 15 Rehermann B, Michitaka K, Durazzo M, Mergener Velev, P, Manns M. Viruses and autoimmune hepatitis. Eur J Clin Invest 1994; 24: 11–19.
- 16 Ferri C, La Civita, L, Cirafisi C, Siciliano G, Longombardo G, Bombardieri S et al. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiological investigations. J Rheumatol 1992; 19: 889–95.
- 17 Kent JF, Fife EH. Precise standardization of reagent for complement fixation. Am J Trop Med Hyg 1963; 12: 103–10.
- 18 Ferri C, Pontrandolfo A, Puccetti A, Migliorini P, Bombardieri S. Cold-dependent in vitro activation of complement in immune complex diseases. Clin Res 1984; 32: 463A.
- 19 Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 1989; 83: 1066–72.
- 20 Bunn CC, Gharavi AE, Hughes GRV. Antibodies to extractable nuclear antigens in 173 patients with DNA binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigen observed by counterimmunoelectrophoresis. J Clin Lab Immunol 1982; 8: 13–17.
- 21 Mishiro S, Hoshi Y, Takeda K, Yoshikawa A, Gotanda T, Takahashi K et al. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 1990; ii: 1400–403.
- 22 Michel G, Ritter A, Gerken G, Meyer Zum Buschenfelde KH, Decker R, Manns MP. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 1992; i: 267–9.
- 23 Choo Gl, Kno G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 1989; 244: 359–61.
- 24 Zignego AL, Deny P, Ferary O, Ponzetto A, Gentilini P, Tiollais P et al. Amplification of hepatitis delta virus RNA sequences by polymerase chain reaction: a tool for viral detection and cloning. Mol Cell Probes 1990; 4: 45–51.
- 25 Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992; 15: 382–6.
- 26 Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type li cryoglobulinemia. N Engl J Med 1992; 327: 1490–95.
- 27 Ferri C, Gremignai G, Bombardieri S, Moriconi L, Pontrandolfo A, Vitali C et al. Plasma-exchange in mixed cryoglobulinemia. Effects on renal, liver and neurologic involvement. La Ricerca Clin Lab 1986; 16: 403–11.
- 28 Ferri C, Pietrogrande M, Cecchetti R, Tavoni A, Cefalo A, Buzzetti G et al. Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia. Am J Med 1989; 87: 519–24.
- 29 Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita, L, Vanacore R et al. Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients. Blood 1993; 81: 1132–6.
- 30 Gorevic PD, Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes: implication for relationship of MC to rheumatic and lymphoproliferative diseases. Seminars in Hematology 1991; 28: 79–94.
- 31 Monteverde A, Rivano MT, Allegra GC, Monteverde AI, Zigrossi P, Baglioni P et al. Essential mixed cryoglobulinemia, type II: a manifestation of low-grade malignant lymphoma? Clinical morphological study of 12 cases with special reference to immunohistochemical findings. Acta Haematol 1988; 79: 20–25.
- 32
Pontisso P,
Poon HC,
Tiollais P,
Brechot C.
Detection of hepatitis B virus in mononuclear blood cells.
Br Med J
1984; 288: 1561–66.
10.1136/bmj.288.6430.1563 Google Scholar
- 33 Ferri C, Monti M, La Civita, L, Longombardo G, Greco F, Pasero G et al. Infection of peripheral mononuclear blood cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701–4.
- 34 Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of 'autoimmune hepatitis. Hepatology 1987; 7: 1333–9.
- 35 Magrin S, Craxi A, Fabiano C, Fiorentino G, Almasio P. Palazzo U et al. Hepatitis C virus replication in ‘autoimmune’ chronic hepatitis. J Hepatol 1991; 13: 364–7.
- 36 Lenzi M, Cassani F, Ballardini G, Bianchi FB, Mishiro S, Unoura M et al. Anti-HCV, anti-GOR, and autoimmunity. Lancet 1992; i: 871–2.
- 37 McFarlane IG. Autoimmunity and hepatotropic viruses. Seminars in Liver Diseses 1991; 11: 223–33.
- 38 Ferri C, La Civita, L, Longombardo G, Lombardini F, Pasero G, Zignego AL et al. Hepatitis C virus in mixed cryoglobulinaemia and B-cell lymphoma. Clin Exp Rheumatol 1994; 12: 89–90.
- 39 Pozzato G, Moretti M, Franzin F, Croce SL, Tiribelli C, Masayu T et al. Severity of liver disease with different hepatitis C viral clones. Lancet 1991; ii: 509.